Mandy van Brakel - Concepedia

Author

Mandy van Brakel

Erasmus MC Cancer Institute ORCID

Also Known As

Brakel, Mandy Van, M. Brakel, M. van Brakel, Mandy Van Brakel, Mandy v Brakel, Mandy van Brakel

Publications

451

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Cancer Institute Erasmus MC UCLouvain Erasmus University Rotterdam de Duve Institute

About

Mandy van Brakel is an author at Erasmus MC Cancer Institute specializing in t cell immunity, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	77
2	Cell Biology	2	2	77
3	Immunology	2	2	77
4	Cellular Therapies	1	1	32
5	Autoimmune Disease	1	1	45

Mandy van Brakel

Publications

428

Citations

H-Index

Page 1

	Year	Citations
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient Imran Siddiqui, Marco Erreni, Mandy van Brakel, Journal for ImmunoTherapy of Cancer	2016	109
CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab André Kunert, Edwin A. Basak, Daan P. Hurkmans, Journal for ImmunoTherapy of Cancer	2019	55
TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity Coen Govers, Zsolt Sebestyén, Mandy van Brakel, The Journal of Immunology T-regulatory CellImmunologyImmunologic MechanismAntigen ProcessingCd4 T Cell Responses	2014	45
TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets Trudy Straetemans, Mandy van Brakel, Sabine van Steenbergen, Clinical and Developmental Immunology	2012	41
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy Mirjam de With, Daan P. Hurkmans, Esther Oomen‐de Hoop, Cancers	2021	40
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody Mesha Saeed, Mandy van Brakel, Sara Zalba, International Journal of Nanomedicine	2016	34
T Cell Receptor-Engineered T Cells to Treat Solid Tumors: T Cell Processing Toward Optimal T Cell Fitness C. B. H. W. Lamers, Sabine van Steenbergen‐Langeveld, Mandy van Brakel, Human Gene Therapy Methods Cell TherapyT-regulatory CellImmunologyTreat Solid TumorsRegulatory T Cells	2014	32
MAGE-C2–Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses André Kunert, Mandy van Brakel, Sabine van Steenbergen‐Langeveld, The Journal of Immunology	2016	32
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer Daan P. Hurkmans, Els M.E. Verdegaal, Sabrina A. Hogan, Journal for ImmunoTherapy of Cancer	2020	17
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients Bas Weenink, Mandy van Brakel, Rebecca Wijers, Journal of Neuro-Oncology	2019	13

Page 1